[go: up one dir, main page]

WO2006046114A3 - Formes posologiques osmotiques a taux croissant de liberation du medicament, et leurs procedes de preparation - Google Patents

Formes posologiques osmotiques a taux croissant de liberation du medicament, et leurs procedes de preparation Download PDF

Info

Publication number
WO2006046114A3
WO2006046114A3 PCT/IB2005/003183 IB2005003183W WO2006046114A3 WO 2006046114 A3 WO2006046114 A3 WO 2006046114A3 IB 2005003183 W IB2005003183 W IB 2005003183W WO 2006046114 A3 WO2006046114 A3 WO 2006046114A3
Authority
WO
WIPO (PCT)
Prior art keywords
dosage forms
processes
preparation
osmotic dosage
drug release
Prior art date
Application number
PCT/IB2005/003183
Other languages
English (en)
Other versions
WO2006046114A2 (fr
Inventor
Rajan Kumar Verma
Narayanan Badri Viswanathan
Rajeev Singh Raghuvanshi
Ashok Rampal
Original Assignee
Ranbaxy Lab Ltd
Rajan Kumar Verma
Narayanan Badri Viswanathan
Rajeev Singh Raghuvanshi
Ashok Rampal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd, Rajan Kumar Verma, Narayanan Badri Viswanathan, Rajeev Singh Raghuvanshi, Ashok Rampal filed Critical Ranbaxy Lab Ltd
Publication of WO2006046114A2 publication Critical patent/WO2006046114A2/fr
Publication of WO2006046114A3 publication Critical patent/WO2006046114A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention porte sur des formes posologiques osmotiques à taux croissant de libération du médicament, et sur leurs procédés de préparation.
PCT/IB2005/003183 2004-10-25 2005-10-25 Formes posologiques osmotiques a taux croissant de liberation du medicament, et leurs procedes de preparation WO2006046114A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2081/DEL/2004 2004-10-25
IN2081DE2004 2004-10-25

Publications (2)

Publication Number Publication Date
WO2006046114A2 WO2006046114A2 (fr) 2006-05-04
WO2006046114A3 true WO2006046114A3 (fr) 2006-10-26

Family

ID=35871202

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/003183 WO2006046114A2 (fr) 2004-10-25 2005-10-25 Formes posologiques osmotiques a taux croissant de liberation du medicament, et leurs procedes de preparation

Country Status (1)

Country Link
WO (1) WO2006046114A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7419684B2 (en) 2006-12-22 2008-09-02 Reliant Pharmaceuticals, Inc. System and method for manufacturing oral osmotic drug delivery devices, and methods of administering same
KR20140069381A (ko) 2009-06-02 2014-06-10 다우 글로벌 테크놀로지스 엘엘씨 서방출 투여형
US10195153B2 (en) 2013-08-12 2019-02-05 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (fr) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Comprimé extrudé anti-abus à libération prolongée
AU2015290098B2 (en) 2014-07-17 2018-11-01 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
CA2964628A1 (fr) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Forme galenique anti-abus de remplissage de liquide a liberation prolongee
CN106560177A (zh) * 2015-09-30 2017-04-12 深圳翰宇药业股份有限公司 一种曲格列汀药物组合物及其制备方法
WO2017115328A1 (fr) 2015-12-31 2017-07-06 Cadila Healthcare Limited Forme pharmaceutique osmotique à libération prolongée comprenant une charge est levée de chlorhydrate de méthylphénidate

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US5024843A (en) * 1989-09-05 1991-06-18 Alza Corporation Oral hypoglycemic glipizide granulation
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
US5713852A (en) * 1995-06-07 1998-02-03 Alza Corporation Oral dosage and method for treating painful conditions of the oral cavity
WO1999062496A1 (fr) * 1998-06-03 1999-12-09 Alza Corporation Procedes et dispositifs servant a maintenir un effet therapeutique prolonge
US20040170680A1 (en) * 2001-05-02 2004-09-02 Benjamin Oshlack Once-a-day oxycodone formulations
WO2006030402A2 (fr) * 2004-09-17 2006-03-23 Ranbaxy Laboratories Limited Dispositif d'administration osmotique a deux compartiments

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US5024843A (en) * 1989-09-05 1991-06-18 Alza Corporation Oral hypoglycemic glipizide granulation
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
US5713852A (en) * 1995-06-07 1998-02-03 Alza Corporation Oral dosage and method for treating painful conditions of the oral cavity
WO1999062496A1 (fr) * 1998-06-03 1999-12-09 Alza Corporation Procedes et dispositifs servant a maintenir un effet therapeutique prolonge
US20040170680A1 (en) * 2001-05-02 2004-09-02 Benjamin Oshlack Once-a-day oxycodone formulations
WO2006030402A2 (fr) * 2004-09-17 2006-03-23 Ranbaxy Laboratories Limited Dispositif d'administration osmotique a deux compartiments

Also Published As

Publication number Publication date
WO2006046114A2 (fr) 2006-05-04

Similar Documents

Publication Publication Date Title
WO2006128693A3 (fr) Derives de 2-oxo-1-pyrrolidine, procedes de preparation de ceux-ci et utilisations de ceux-ci
AP2405A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms.
WO2006023627A8 (fr) Polymorphes de rapamycine et leurs utilisations
EP1740156B8 (fr) Procede de production d'une forme galenique solide protegee contre un usage detourne
WO2005079756A3 (fr) Methodes et compositions de traitement de troubles psychiatriques
WO2007019439A3 (fr) Compositions de copolymere sequence et utilisations de ces dernieres
WO2006060547A3 (fr) Systemes et methodes d'administration intra-orale de medicaments
WO2007022956A3 (fr) Compositions pharmaceutiques
WO2006131591A3 (fr) Forme posologique destinee a etre administree par voie orale
WO2008070269A3 (fr) Procédés, logiciel et systèmes d'imagerie
WO2007001888A3 (fr) Nouveaux schemas posologiques pour dispositifs de liberation controlee de medicament de contraception
WO2008121767A3 (fr) Polypeptides cousus
WO2006007448A3 (fr) Compositions pharmaceutiques de co-cristal et methodes d'utilisation associees
WO2007014930A3 (fr) Copolymeres de polyammonium-polysiloxane
WO2009042114A3 (fr) Dérivés de phénazine et leurs utilisations
WO2006055603A3 (fr) Formulations injectables de nanoparticules d'olanzapine
WO2007147010A3 (fr) Appareils médicaux implantables et méthodes pour les fabriquer
IL180397A0 (en) Diamine derivatives, fungicidal compositions containing the same, and processes for the preparation thereof
WO2007050793A3 (fr) Methodes et compositions de traitement du syndrome de marfan et de troubles associes
WO2006118884A3 (fr) Dispositifs d'administration de medicaments, composants, systemes et methodes associes
WO2006113568A8 (fr) Combinaison de tramadol et de matieres renfermant la gabapentine
AP2006003495A0 (en) Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections.
WO2007133944A3 (fr) Administration topique d'acyclovir
WO2007075980A3 (fr) Comprimes de lansoprazole se desintegrant oralement
WO2006046114A3 (fr) Formes posologiques osmotiques a taux croissant de liberation du medicament, et leurs procedes de preparation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV LY MD MG MK MN MW MX MZ NA NG NO NZ OM PG PH PL PT RO RU SC SD SG SK SL SM SY TJ TM TN TR TT TZ UG US UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SZ TZ UG ZM ZW AM AZ BY KG MD RU TJ TM AT BE BG CH CY DE DK EE ES FI FR GB GR HU IE IS IT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05809777

Country of ref document: EP

Kind code of ref document: A2